Travere Therapeutics Inc. buy melinda
Start price
23.03.17
/
50%
€15.69
Target price
03.04.17
€19.39
Performance (%)
5.40%
End price
03.04.17
€16.54
Summary
This prediction ended on 03.04.17 with a price of €16.54. With a performance of 5.40%, the BUY prediction by melinda for Travere Therapeutics Inc. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Travere Therapeutics Inc. | 11.047% | 11.047% | 117.045% | - |
| iShares Core DAX® | 4.642% | 7.489% | 6.987% | 53.734% |
| iShares Nasdaq 100 | 4.471% | 16.803% | 40.281% | 104.329% |
| iShares Nikkei 225® | 7.670% | 16.856% | 47.874% | 73.793% |
| iShares S&P 500 | 2.472% | 9.903% | 28.430% | 72.579% |
Comments by melinda for this prediction
In the thread Travere Therapeutics Inc. diskutieren
Gesundheit | Arzneimittelhersteller - Wichtige | Vereinigte Staaten
a +
(Vom Mitglied beendet)


